ideaPoint and WideTrial Launch Global Expanded Access Platform for COVID-19 Medicines

    NEXT STORY
    FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics
    PREV STORY
    BioNTech Announces Full Year 2019 Financial Results and Corporate Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Pacira BioSciences Launches National Regional Anesthesia Training Initiative with Envision Physician Services

    author_avatar
    NASDAQ Market News

    Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference

    CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a ...

    author_avatar
    NASDAQ Market News

    Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH

    author_avatar
    NASDAQ Market News